These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 601175)

  • 1. Dextro- and L-amphetamine are equipotent in releasing human growth hormone.
    Langer G; Matussek N
    Psychoneuroendocrinology; 1977 Oct; 2(4):379-82. PubMed ID: 601175
    [No Abstract]   [Full Text] [Related]  

  • 2. Amphetamines, growth hormone and narcolepsy.
    Parkes JD; Debono AG; Jenner P; Walters J
    Br J Clin Pharmacol; 1977 Jun; 4(3):343-9. PubMed ID: 901702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol and GH responses to D- and L-amphetamine in monkeys.
    Marantz R; Sachar EJ; Weitzman E; Sassin J
    Endocrinology; 1976 Aug; 99(2):459-65. PubMed ID: 954645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuroendocrine and behavioral response to dextroamphetamine in normal individuals.
    Dommisse CS; Schulz SC; Narasimhachari N; Blackard WG; Hamer RM
    Biol Psychiatry; 1984 Sep; 19(9):1305-15. PubMed ID: 6149772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of amphetamines on plasma corticosteroid and growth hormone levels in man.
    Besser GM; Butler PW; Landon J; Rees L
    Br Med J; 1969 Nov; 4(5682):528-30. PubMed ID: 4311188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute dextro-amphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3 and 18.8 T.
    McGrath BM; McKay R; Dave S; Seres P; Weljie AM; Slupsky CM; Hanstock CC; Greenshaw AJ; Silverstone PH
    Neurosci Res; 2008 Aug; 61(4):351-9. PubMed ID: 18508145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy.
    Parkes JD; Fenton GW
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):1076-81. PubMed ID: 4359162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate.
    Brown WA; Corriveau DP; Ebert MH
    Psychopharmacology (Berl); 1978 Jul; 58(2):189-95. PubMed ID: 98790
    [No Abstract]   [Full Text] [Related]  

  • 10. Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study.
    Silverstone PH; O'Donnell T; Ulrich M; Asghar S; Hanstock CC
    Hum Psychopharmacol; 2002 Dec; 17(8):425-9. PubMed ID: 12457379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOXICITY AND CATECHOLAMINE RELEASING ACTIONS OF D- AND L-AMPHETAMINE IN ISOLATED AND AGGREGATED MICE.
    MOORE KE
    J Pharmacol Exp Ther; 1963 Oct; 142():6-12. PubMed ID: 14076523
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormonal responses to dextroamphetamine in depressed and normal adolescents.
    Waterman GS; Ryan ND; Puig-Antich J; Meyer V; Ambrosini PJ; Rabinovich H; Stull S; Novacenko H; Williamson DE; Nelson B
    J Am Acad Child Adolesc Psychiatry; 1991 May; 30(3):415-22. PubMed ID: 2055877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers.
    Asghar SJ; Tanay VA; Baker GB; Greenshaw A; Silverstone PH
    Hum Psychopharmacol; 2003 Jun; 18(4):291-9. PubMed ID: 12766934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute psychosis caused by dextro-amphetamine.
    WALLIS GG; McHARG JF; SCOTT OC
    Br Med J; 1949 Dec; 2(4641):1394. PubMed ID: 15397507
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of imipramine antidepressant response by a one-day dextro-amphetamine trial.
    van Kammen DP; Murphy DL
    Am J Psychiatry; 1978 Oct; 135(10):1179-84. PubMed ID: 358845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine response in borderline patients.
    Schulz SC; Schulz PM; Dommisse C; Hamer RM; Blackard WG; Narasimhachari N; Friedel RO
    Psychiatry Res; 1985 Jun; 15(2):97-108. PubMed ID: 3862151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma GH response to D- and L-amphetamine in monkeys.
    Smith GP; Russ RD; Stokes P; Ducket GE; Root AW
    Horm Metab Res; 1977 Jul; 9(4):339-40. PubMed ID: 408256
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth hormone response to dextroamphetamine in depressed patients and normal subjects.
    Halbreich U; Sachar EJ; Asnis GM; Quitkin F; Nathan RS; Halpern FS; Klein DF
    Arch Gen Psychiatry; 1982 Feb; 39(2):189-92. PubMed ID: 7065832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anorexigenic action of dextro-amphetamine sulfate upon feeding responses of differing strength.
    SIEGEL PS; STERLING TD
    J Comp Physiol Psychol; 1959 Apr; 52(2):179-82. PubMed ID: 13654572
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of dextro-amphetamine in severe behavior problems of children.
    GINN SA; HOHMAN LB
    South Med J; 1953 Nov; 46(11):1124-7. PubMed ID: 13113418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.